Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Inventory Average (2022 - 2023)

Amylyx Pharmaceuticals has reported Inventory Average over the past 2 years, most recently at $35.3 million for Q4 2023.

  • Quarterly results put Inventory Average at $35.3 million for Q4 2023, up 584.25% from a year ago — trailing twelve months through Dec 2023 was $35.3 million (up 584.25% YoY), and the annual figure for FY2023 was $24.0 million, changed.
  • Inventory Average for Q4 2023 was $35.3 million at Amylyx Pharmaceuticals, up from $28.6 million in the prior quarter.
  • Over the last five years, Inventory Average for AMLX hit a ceiling of $35.3 million in Q4 2023 and a floor of $5.2 million in Q4 2022.